Discover how the final rule from the CDC expands access to the World Trade Center (WTC) Health Program, now including Pentagon and Shanksville responders. This course unpacks the statutory changes, capped at 500 new enrollees, detailing the impact and compliance with...
Telemedicine Regulations for Buprenorphine Prescription
$49.99
Gain crucial insights into the expanded telemedicine regulations that allow practitioners to prescribe schedule III-V controlled substances for opioid use disorder treatment. Learn how to navigate these new rules, understand the necessary compliance steps, and the potential repercussions of non-compliance. This course equips you to effectively use telemedicine for OUD treatment, ensuring continuity of care.
In this course you will learn the following:
* Understand the scope and purpose of the new telemedicine regulations.
* Identify the key requirements for prescribing buprenorphine via telemedicine.
* Implement the necessary steps to comply with the regulations.
* Recognize the legal and financial repercussions of non-compliance.
Listen to a short Podcast discussing this course:
NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.
Additional information
Federal Register Title | Expansion of Buprenorphine Treatment via Telemedicine Encounter. Document Number: 2025-01049 |
---|---|
Course SKU | FR-25-509-1 |
Why This Course Is Important | Failing to understand and implement these telemedicine regulations can lead to legal penalties, loss of medical licenses, and hindered ability to provide continuous care for patients with opioid use disorder. |